Table 2 Patient characteristics after propensity score matching
Variables | Non-Wrapping Group (n = 48) | Wrapping Group (n = 48) | P value | |
|---|---|---|---|---|
Sex | Female | 16(33.3%) | 20(41.7%) | 0.399 |
Male | 32(66.7%) | 28(58.3%) | ||
Age (years) | 62(13) | 65(10) | 0.156 | |
BMI (kg/m2) | 21.27(19.00–23.81) | 21.20(19.55–22.67) | 0.750 | |
Hypertension | 13(27.1%) | 10(20.8%) | 0.473 | |
Diabetes | 8(16.7%) | 3(6.3%) | 0.109 | |
Primary disease | ||||
Pancreatic ductal adenocarcinoma | 22(45.8%) | 26(54.2%) | ||
Ampullary carcinoma | 7(14.6%) | 8(16.7%) | ||
Adenocarcinoma of the duodenum | 15(31.3%) | 8(16.7%) | 0.557 | |
Cholangiocarcinoma | 3(6.3%) | 4(8.3%) | ||
Chronic pancreatitis | 1(2.1%) | 2(4.2%) | ||
Liver function | ||||
ALT (U/L) | 88(38–197) | 125(28–250) | 0.468 | |
AST (U/L) | 69(30–130) | 72(25–181) | 0.679 | |
TBIL (umol/L) | 75.2(10.2–165.3) | 72.0(13.7–178.3) | 0.817 | |
ALB (g/L) | 36.4(33.8–39.3) | 38.7(34.2–42.8) | 0.057 | |
Tumor markers | ||||
CA-199(U/mL) | 61.45(19.49–442.85) | 102.53(14.74–411.2) | 0.918 | |
CA-125(U/mL) | 23.40(11.40–34.85) | 23.40(9.42–34.48) | 0.866 | |
CEA (ng/mL) | 2.24(1.58–3.26) | 2.57(1.50–4.30) | 0.364 | |
Pancreatic CT value (Hu) | 35(30–40) | 34(31–40) | 0.912 | |
Main pancreatic diameter(mm) | 4.08(3.05–5.47) | 3.95(2.63–5.35) | 0.644 | |
ASA classification | I | 1(2.1%) | 0 | 0.534 |
II | 20(41.7%) | 19(39.6%) | ||
III | 26(54.2%) | 29(60.4%) | ||
IV | 1(2.1%) | 0 | ||